VIRTUAL PANEL SERIES
NEW FOR 2020
The buzz around the potential of Precision Medicine continues as new technologies, more powerful computing and our ability to store, share and interpret Big Data increases. Yet with differing healthcare systems, regulatory obstacles, reimbursement challenges, ethical concerns and many more issues, there are a multitude of hurdles to overcome before we will see ubiquitous precision medicine. Of course, the ultimate goal is to achieve clinical implementation of a personalised medicine approach.
It will take the combined efforts of healthcare providers, research, industry, Government and patient groups, as well as harnessing the undoubted potential of technology, to realise the potential of precision medicine. By bringing these groups together we hope to help break down these barriers
Our aim is to facilitate global collaboration in precision medicine – what many see as the key to unlocking the promise of a personalised approach to healthcare. We do this through our events, social media, newsletters and our website. Join us and let’s make a difference together.
To learn more about our upcoming events please click the links or view them all here. For our latest interviews, guest blogs, news and more just scroll down.
“…a great event which surpassed my expectations; one of the best conferences I have been to for yearsVP and Head, Genome Sciences & Technologies, Worldwide R&D Pfizer Inc.
$1.3million grant awarded to researchers to study precise treatment for neuroblastoma
The Christie NHS Foundation Trust and Cancer Research UK Manchester have been awarded a...
NewsCancer Patients may not need a scan due to New Blood Test
The new blood test could mean that doctors will be able to see if a cancer treatment is working...
NewsArtificial Intelligence to be used in a study for Alzheimer’s Drug Development
Perelman School of Medicine at the University of Pennsylvania will use artificial intelligence...
NewsNorwegian Government increases Precision Medicine state funding to NOK 61,3 Million
In the state’s budget released this week, the Norwegian Government raised the funding for...
NewsProf Kjetil Tasken speaking about the cost of CAR T-cells therapy and inequalities in cancer treatment
Prof Kjetil Tasken speaks about CAR T-cells therapy and inequalities in cancer treatment...
FeaturesProf. Magnus Essand, of Uppsala University, speaks about oncolytic viruses and their potential as a treatment option
Prof. Magnus Essand, of Uppsala University, joined us for our Virtual Panel Discussion on...
FeaturesProf. Ann Ager, of Cardiff University, speaks about the development of CAR-T Cells
During our Virtual Panel Series discussion on December 17th, our expert panellist’s discussed,...
FeaturesProf. Rob Jones, of Cancer Research UK Glasgow Clinical Trials Unit, speaks about clinical trials
Prof. Rob Jones, of Cancer Research UK Glasgow Clinical Trials Unit, speaks about the next...
FeaturesDr. Capucine Baldini, speaks about how Gustave Roussy dealt with the first and second waves of the pandemic
Dr. Capucine Baldini, of Gustave Roussy, speaks about how Gustave Roussy dealt with the first...
FeaturesEibhlin Mulroe, of Cancer Trials Ireland, speaks about the re-opening of hospital sites for clinical trials
Eibhlin Mulroe spoke to PMF about the difficulties of performing clinical trials in hospitals...
FeaturesPrecision Medicine vs Lily’s fight for survival
7-year-old Lily and her family have fought tirelessly to find clinical Precision Medicine...
Blog PostsPMF Interviews Dr. Bettina Lundgren, CEO and Managing Director, Danish National Genome Centre
CEO and Managing Director, of the Danish National Genome Centre, insights into the Danish...
Blog PostsPMF Interviews Dr. Toni Andreu, Scientific Director, EATRIS
The next interview in our Nordic Precision Medicine Forum 2020/21 series is one we conducted...
Blog PostsPMF Interviews Dr Valtteri Wirta, Speaker at Nordic Precision Medicine Forum 2020/2021
PMF Interviews Dr Valtteri Wirta, Speaker at the Virtual Nordic Precision Medicine Forum 2020/2021...
Blog PostsPharmacogenomics (PGx): The New Frontier in Medication Use
Pharmacogenomics (PGx) has potential to revolutionize current and future medication therapy....
Blog PostsGENETIC INFORMATION WILL BE PART OF ROUTINE HEALTHCARE IN FINLAND
This short blog and video features Markus Perola, Research Professor at Finland’s National...
Blog Posts